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Background/Objective: The cardiac Na+/Ca2+ exchanger (NCX) has been identified
as a promising target to counter arrhythmia in previous studies investigating the benefit of
NCX inhibition. However, the consequences of NCX inhibition have not been investigated
in the setting of altered NCX expression and function, which is essential, since major
cardiac diseases (heart failure/atrial fibrillation) exhibit NCX upregulation. Thus, we here
investigated the effects of the NCX inhibitor SEA0400 on the Ca2+ transient amplitude
and on proarrhythmia in homozygous NCX overexpressor (OE) and heterozygous NCX
knockout (hetKO) mice compared to corresponding wild-types (WTOE/WThetKO).
Methods/Results: Ca2+ transients of field-stimulated isolated ventricular
cardiomyocytes were recorded with fluo-4-AM or indo-1-AM. SEA0400 (1 µM)
significantly reduced NCX forward mode function in all mouse lines. SEA0400 (1
µM) significantly increased the amplitude of field-stimulated Ca2+ transients in WTOE,
WThetKO, and hetKO, but not in OE (% of basal; OE= 98.7± 5.0; WTOE = 137.8 ± 5.2
∗;
WThetKO = 126.3± 6.0
∗; hetKO= 140.6± 12.8∗; ∗p < 0.05 vs. basal). SEA0400 (1 µM)
significantly reduced the number of proarrhythmic spontaneous Ca2+ transients (sCR)
in OE, but increased it in WTOE, WThetKO and hetKO (sCR per cell; basal/+SEA0400;
OE = 12.5/3.7; WTOE = 0.2/2.4; WThetKO = 1.3/8.8; hetKO = 0.2/5.5) and induced
Ca2+ overload with subsequent cell death in hetKO.
Conclusion: The effects of SEA0400 on Ca2+ transient amplitude and the occurrence of
spontaneous Ca2+ transients as a proxy measure for inotropy and cellular proarrhythmia
depend on the NCX expression level. The antiarrhythmic effect of SEA0400 in conditions
of increased NCX expression promotes the therapeutic concept of NCX inhibition in
heart failure/atrial fibrillation. Conversely, in conditions of reduced NCX expression,
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SEA0400 suppressed the NCX function below a critical level leading to adverse
Ca2+ accumulation as reflected by an increase in Ca2+ transient amplitude,
proarrhythmia and cell death. Thus, the remaining NCX function under inhibition may
be a critical factor determining the inotropic and antiarrhythmic efficacy of SEA0400.
Keywords: Na+/Ca2+ exchanger, arrhythmia, heart failure, novel antiarrhythmic strategies, Ca2+ cycling,
transgenic mice
INTRODUCTION
Approximately 25% of cardiovascular mortality has been
attributed to sudden cardiac death (Priori et al., 2015). Except
for betablockers, conventional antiarrhythmic drugs targeting
Na+, Ca2+, or K+ channels have not been shown to prevent
sudden cardiac death. Due to these unsatisfying results, much
effort has been made to identify alternative targets to prevent
from life threatening arrhythmias. In this regard, heart failure—
the most prevalent precondition for sudden cardiac death—
is accompanied by an upregulation of the cardiac Na+/Ca2+
exchanger (NCX) (Menick et al., 2007). NCX is the dominant
mechanism for the extrusion of Ca2+ out of the cell. In its
electrogenic forwardmode NCX extrudes 1 Ca2+ ion in exchange
for 3 Na+ ions thus generating a net electrical inward current
that depolarizes the cellular membrane potential. In the setting of
increased NCX expression—as observed in heart failure or atrial
fibrillation—NCX-mediated depolarization is enhanced leading
to a prolongation of the action potential duration and favoring
the occurrence of early and delayed afterdepolarizations (EADs,
DADs). Thus, increased NCX function is regarded as a crucial
factor for increased triggered activity and whole heart arrhythmia
(Sipido et al., 2006; Pott et al., 2012; Bourgonje et al., 2013).
Conversely, we have recently shown that reduced NCX
expression in a murine model with heterozygous knockout
of the NCX gene leads to suppression of EADs and DADs
(Bögeholz et al., 2015) supporting the above stated hypothesis.
Others have evaluated the pharmacological (Nagy et al., 2004;
Tanaka et al., 2007; Milberg et al., 2012) inhibition of NCX
as an antiarrhythmic strategy. The majority of these studies
used the NCX inhibitor SEA0400. Within the group of potent
NCX inhibitors, previously represented by the peptide XIP (Li
et al., 1991) and the isothiourea derivative KB-R7943 (Iwamoto
et al., 1996), SEA0400 was introduced around the millennium.
SEA0400 was considered as a major advance, especially due to
its improved selectivity and high potency as compared to the
mentioned precursors (Nagy et al., 2004). In later studies, the
selectivity of SEA0400 has been debated and relativized (Reuter
et al., 2002; Birinyi et al., 2005, 2008) due to relevant inhibitory
efficacy on the L-type Ca2+ channel on higher concentrations
(Birinyi et al., 2005). Other than XIP, SEA0400 is able to permeate
the cell membrane. Encouragingly, the majority of studies to
investigate the effect of SEA0400 on arrhythmia reported positive
results, i.e., antiarrhythmic efficacy (Nagy et al., 2004; Milberg
et al., 2012) in absence of negative inotropic effects (Bourgonje
et al., 2013) thus potentially qualifying the concept of NCX
inhibition as a promising antiarrhythmic strategy. However,
there is also data suggesting unbeneficial effects of SEA0400 in the
form of increased proarrhythmia (Ozdemir et al., 2008). These
studies investigated various animal models and species in the
absence or presence of heart failure and partially applied cardiac
glycosides, that reduce the NCX forward mode function (O’Neill
et al., 1990), to provoke arrhythmia (Nagasawa et al., 2005;
Namekata et al., 2009; Nagy et al., 2014). Thus, NCX function
was either enhanced due to an increased NCX expression in
heart failure models or already reduced by cardiac glycosides
which reduce the NCX driving force by increasing intracellular
Na+. To the best of our knowledge, there is no study that
evaluated the antiarrhythmic and inotropic effects of NCX
inhibition by SEA0400 in dependence of the NCX expression
and function level. However, this aspect is crucial, since major
cardiac diseases like heart failure and atrial fibrillation (Voigt
et al., 2012) are accompanied by NCX upregulation, which
critically affects cardiac Ca2+ cycling. On the contrary, there are
cardiac disease entities that exhibit a reduced NCX function,
like the postinfarction (Zhang et al., 1996; Quinn et al., 2003)
and diabetic cardiomyopathy (Schaffer et al., 1997; Hattori et al.,
2000; Zhao et al., 2014). Thus, we here used a murine model
of increased (Adachi-Akahane et al., 1997; Pott et al., 2012) or
decreased (Henderson et al., 2004; Bögeholz et al., 2015) NCX
expression (and consequently function) and corresponding wild-
type mice to evaluate the effects of SEA0400 on Ca2+ transient
amplitudes as a proxy measure for inotropy and the occurrence
of proarrhythmic Ca2+ releases in dependence of the NCX
expression level. Since chronic reduction of NCX expression and
function has been demonstrated to prevent arrhythmia (Bögeholz
et al., 2015), another more fundamental question to be addressed
in this study is, whether acute pharmacological NCX inhibition
similarly mediates antiarrhythmic effects. And if so, whether
this antiarrhythmic effect does apply exclusively to the setting
of increased NCX expression and/or function vs. reduced NCX
function, bearing a potential answer toward the question whether
there is an optimum of NCX function in the face of inotropy and
arrhythmia.
METHODS
NCX Transgenic Mouse Models
Generation of global homozygous NCX overexpressor (OE)
(Adachi-Akahane et al., 1997) and heterozygous knockout
(hetKO) (Jordan et al., 2010) mouse model has been described
previously. The genetic background of OE mice is C57BL/6 (Pott
et al., 2012), whereas hetKO mice are on a combined genetic
background of C57BL/6 and CD-1 due to embryonic transfer
(Bögeholz et al., 2016). Animals entering experimentation
were <12.5 weeks of age, since up to this age there is
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no evidence for structural remodeling or heart failure in
OE (Pott et al., 2012) or hetKO mice (Jordan et al., 2010;
Bögeholz et al., 2015). All experiments were approved by
the local animal welfare authorities (Landesamt für Natur,
Umwelt, und Verbraucherschutz NRW, permission number:
8.84-02.05.20.11.098) and conform to the guidelines from
Directive 2010/63/EU of the European Parliament on the
protection of animals used for scientific purposes.
Isolation of Ventricular Cardiomyocytes
Ventricular cardiomyocytes were isolated from OE, hetKO
and respective wild-type mice (WTOE/WThetKO) as previously
described with minor alterations (Schulte et al., 2012; Bögeholz
et al., 2015). Mice were sedated and euthanized by carbon dioxide
inhalation. Hearts were explanted immediately after decease and
perfused retrogradely for 1 min via the aorta with a perfusion
solution containing in mM: NaCl 113, KCl 4.7, KH2PO4 0.6,
Na2HPO4 0.6, MgSO4 1.2, NaHCO3 12, KHCO3 10, taurine
30, HEPES 10, glucose 11.1, BDM 10, heparin 14.3 IE/ml, pH
= 7.4. To isolate rod-shaped viable ventricular myocytes, the
extracellular connective tissue was degraded by perfusion for
6 min± 10 s on 37.1◦C with the perfusion solution containing
Collagenase type 2 (Worthington Biochemical Corporation) and
Protease from streptomyces griseus type XIV (Sigma Aldrich).
Ca2+ Epifluorescence Measurements
Technical and procedural aspects of Ca2+ epifluorescence
measurement have been described in detail before (Pott
et al., 2012; Bögeholz et al., 2015). Data acquisition was
performed using a Ca2+ imaging system, composed of a
DeltaRAM monochromator and two Type-710 photomultiplier
(Photon Technology International, USA) mounted to an inverse
microscope (Diaphot 200, Nikon, Japan). Cardiomyocytes were
transferred to a custom-made recording chamber and field-
stimulated by platinum wires (Type 223 Stimulator CS, Hugo
Sachs Elektronik- Harvard Apparatus, Germany). Fluorescence
signals were recorded by FeliX 1.42 software (Photon Technology
International, USA). The following external solution (Tyrode’s
solution) has been applied; in mM: NaCl 140, KCl 5.8, KH2PO4
0.5, Na2HPO4 0.4 MgSO4 0.9, HEPES 10, glucose 11.1, CaCl2
2, pH = 7.3. Experiments were performed at room temperature.
The NCX function was assessed by the decay of caffeine (10 mM)
induced Ca2+ transients (Bassani et al., 1994; Bögeholz et al.,
2015, 2016) using fluo-4-AM (excitation: 488 nm, emission:
522 nm). The ratiometric fluorescent Ca2+ indicator indo-1-AM
was employed to record field-stimulated Ca2+ transients and
proarrhythmic spontaneous Ca2+ activity (excitation: 344 nm,
emission-ratio: 405/495 nm). The amplitude of field-stimulated
Ca2+ transients served as a proxy measure for inotropy. The
most chosen SEA0400 concentration is 1 µM (Farkas et al., 2008;
Namekata et al., 2009; Bourgonje et al., 2013; Nagy et al., 2014).
Since previous studies demonstrated a relevant inhibitory effect
of SEA0400 on other molecular targets next to NCX, such as
the L-type Ca2+ channel, at concentrations higher than 1 µM
(Birinyi et al., 2005) we decided not to exceed this threshold.
Since we could observe an effect of SEA0400 on Ca2+ transient
dynamics in initial dose-response experiments in a range between
0.3 and 1 µM, we decided to apply both concentrations.
Statistics
Statistical calculations were conducted with SigmaPlot 11.2
(Systat Software; Inc.). Numerical results are expressed as mean
value± standard error of the mean (SEM). Number of replicates
are indicated as n = number of independently analyzed
cardiomyocytes/number of mice used for cardiomyocyte
isolation. Data were analyzed by ANOVA on ranks followed by
Dunn’s post hoc test or repeated measures ANOVA followed by
Holm-Sidak post hoc test. Rates and proportions were quantified
using the Fisher’s exact test with R.
RESULTS
Effects of SEA0400 on NCX-Mediated Ca2+
Removal
To test the inhibitory effect of SEA0400 on the NCX forward
mode, caffeine application experiments were conducted as
reported previously (Bassani et al., 1994; Bögeholz et al., 2015).
Before caffeine was applied, cells were field-stimulated in absence
or presence of SEA0400, respectively, with 1Hz for 1min
followed by 10 s of rest. A faster caffeine-induced Ca2+ transient
decay indicates a higher NCX function.
As demonstrated previously, in absence of SEA0400 (basal
conditions), the time to 50% decay of caffeine-induced Ca2+
transients (T50) was significantly prolonged in heterozygous
hetKO and shortened in OE as compared to the corresponding
WT confirming a reduced/enhanced NCX-mediated Ca2+
removal rate, respectively (T50 in s: OE: 1.2 ± 0.2
+; n = 37/5;
WTOE: 2.0 ± 0.1; n = 42/5; hetKO: 3.3 ± 0.2
+; n = 26/4;
WThetKO: 2.1± 0.2; n= 24/4;
+p < 0.05 OE vs. WTOE or hetKO
vs. WThetKO; ANOVA on ranks test) (Figures 1A–D). When
caffeine was applied in the presence of SEA0400 (1 µM), T50
was significantly increased vs. basal in all mouse lines indicating
the inhibitory effect of SEA0400 on NCX forward mode (T50
in s; 1 µM SEA0400: OE: 2.9 ± 0.4∗; n = 21/3; WTOE: 4.1
± 0.4∗; n = 25/3; hetKO: 5.8 ± 0.4∗; n = 24/3; WThetKO:
4.3 ± 0.4∗; n = 24/3; ∗p < 0.05 vs. basal; ANOVA on ranks
test) (Figures 1B,D). In presence of SEA0400, T50 still tended
to be shortened in OE and prolonged in hetKO compared to
WTOE and WThetKO, respectively, however this finding was not
statistically significant (p > 0.05 each; ANOVA on ranks test).
Notably, the mean T50 value of OE in presence of SEA0400 was
larger than in WTOE/WThetKO but still smaller than in hetKO
under basal conditions indicating a remaining NCX function in
OE ranging between the levels of WTOE/WThetKO and hetKO.
Effects of SEA0400 on the Ca2+ Transient
Amplitude
To test the effects of SEA0400 on the steady-state amplitude of
field-stimulated Ca2+ transients, Ca2+ transients were measured
in absence and presence of 0.3 and 1µM SEA0400. Cells were
field-stimulated at 1Hz for 4min followed by 20 sweeps on
0.125Hz. This protocol was repeated in presence of 0.3 and
1 µM SEA0400 within the same cell. The amplitude of the Ca2+
Frontiers in Pharmacology | www.frontiersin.org 3 September 2017 | Volume 8 | Article 649
Bögeholz et al. SEA0400 Effects Depend on NCX Expression
FIGURE 1 | SEA0400 mediated NCX forward mode inhibition in caffeine application experiments. Representative tracings of caffeine-induced Ca2+ transients
illustrate the different decay rates in OE (A), hetKO (C) and respective WTs as a direct measure of NCX-mediated Ca2+ removal under basal conditions and during
NCX inhibition by SEA0400. Quantification of time to 50% decay (T50) of caffeine-induced Ca
2+ transients confirmed increased NCX forward mode function in OE
(B) and decreased in hetKO (D), and verified NCX forward mode inhibition by SEA0400 in all investigated groups but to different levels. *p < 0.05 vs. basal;
+p < 0.05 OE/hetKO vs. WTOE/WThetKO basal; ANOVA on ranks test.
transient was quantified at the end of the 1Hz pacing phase
after reaching a steady-state in Ca2+ transient kinetics. The Ca2+
transient amplitude in presence of SEA0400 is given in % of basal
conditions.
SEA0400 led to a similar relative increase of the mean Ca2+
transient amplitude in WTOE (n = 27/7), WThetKO (n = 19/4),
and hetKO (n = 19/5). However, in OE (n = 27/8) no increase
of the Ca2+ transient amplitude was observed under application
of SEA0400 (amplitude of field stimulated Ca2+ transients in %
of basal; 1 µM SEA0400: OE: 98.7 ± 5.1; n = 23/8; WTOE: 137.8
± 5.2∗; n= 23/7; hetKO: 140.6± 12.8∗; n= 9/3; WThetKO: 126.3
± 6.0∗; n= 16/4; ∗p < 0.05 vs. basal; repeated measures ANOVA
test) (Figures 2A,B).
Influence of SEA0400 on Proarrhythmic
Spontaneous Ca2+ Transients
To investigate the dependence of the antiarrhythmic effects of
SEA0400 on NCX expression level, we monitored the occurrence
of spontaneous Ca2+ releases (sCR), defined as spontaneously
occurring Ca2+ transients between the field stimulated Ca2+
transients, during the 0.125Hz pacing period in the above stated
protocol before and after SEA0400 administration. An increase
of sCR suggests an increase of proarrhythmia.
Under basal conditions, the occurrence of sCR (Figure 3)
was similar to previously reported findings for OE (Pott et al.,
2012) and hetKO (Bögeholz et al., 2015). The fraction of
cells exhibiting spontaneous Ca2+ transients was significantly
increased in OE compared to WTOE (Figure 3C) (OE: 63%
+,
WTOE: 7%;
+p < 0.05 OE vs. WTOE, Fisher’s exact test with R).
The average number of sCR per cell (Figure 3B) was likewise
increased in OE vs. WTOE (number of sCR/all investigated cells:
OE: 12.5± 3.8+; n= 27/8; WTOE: 0.2± 0.1; n= 27/7;
+p < 0.05
OE vs. WTOE; repeated measures ANOVA).
In hetKO the fraction of cells with sCR (Figure 3C) (hetKO:
5%; n = 19/5 WThetKO: 21%; n = 19/4; p > 0.05 hetKO vs.
WThetKO, Fisher’s exact test with R) as well as mean number of
sCR per cell (Figure 3B) tended to be reduced vs. WThetKO but
the results were not statistically significant (number of sCR/all
investigated cells: hetKO: 0.2± 0.2; WThetKO: 1.3± 1.0; p > 0.05
hetKO vs. WThetKO; repeated measures ANOVA).
Application of SEA0400 altered the occurrence of sCR, but
the specific effect depended upon the basal NCX expression
level. In OE, SEA0400 significantly decreased the mean number
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FIGURE 2 | Relative effect of increasing SEA0400 concentrations on the
amplitude of field stimulated Ca2+ transients as a measure for inotropy.
SEA0400 mediated a significant relative increase of the Ca2+ transient
amplitude vs. basal in WTOE (A), WThetKO and hetKO (B), but not in OE (A).
Thus, the effect of SEA0400 on the Ca2+ transient amplitude seems to
depend on the respective NCX expression level. *p < 0.05 vs. basal; two-way
repeated measures ANOVA test.
of sCR per cell (Figure 3B) (number of sCR/all investigated
cells; 1 µM SEA0400; OE: 3.7 ± 1.0∗; n = 23/8; ∗p < 0.05 vs.
basal; repeated measures ANOVA) without altering the number
of sCR-positive cells (Figure 3C). In contrast, we observed an
increase in the occurrence of sCR in groups with normal or
reduced NCX expression level. In WTOE and WThetKO SEA0400
significantly increased the number of sCR-positive cells to 41
and 71% (Figure 3C). At the same time the occurrence of sCR
per cell was increased significantly in WThetKO and in tendency
in WTOE in response to SEA0400 (Figure 3B) (number of
sCR/all investigated cells; 1 µM SEA0400: WTOE: 2.4 ± 0.8; n
= 23/7; WThetKO: 8.8 ± 1.9
∗; n = 16/4; ∗p < 0.05 vs. basal;
repeated measures ANOVA). In hetKO application of 1 µM
SEA0400 significantly increased both, the occurrence of sCR per
cell (Figure 3B) (number of sCR/all investigated cells; 1 µM
SEA0400: hetKO: 5.5 ± 2.2∗; n = 8/3; ∗p < 0.05 vs. basal;
repeated measures ANOVA) and the number of sCR-positive
cells (Figure 3C) (hetKO: 88%∗; ∗p < 0.05 vs. basal, Fisher’s
exact test with R). Moreover, SEA0400 drastically impaired Ca2+
homeostasis in hetKO as reflected by an abrupt elevation of the
diastolic Ca2+ level, incessant Ca2+ oscillations and subsequent
cell death, defined as Ca2+ hypercontraction (Figure 4), so
that only 42% of all measured hetKO cells could be analyzed.
The fraction of cells suffering from Ca2+ hypercontraction
was significantly increased in hetKO as compared to WThetKO
(Figure 4B) (hetKO: 58%+, WThetKO: 11 %;
+p < 0.05 hetKO
vs. WThetKO, Fisher’s exact test with R) but unaltered between
OE and WTOE (OE: 15%, WTOE: 19%; p > 0.05 OE vs. WTOE,
Fisher’s exact test with R).
DISCUSSION
In the search for novel strategies to counter cardiac arrhythmia,
the cardiac Na+/Ca2+ exchanger (NCX) has been identified as
a potential target. Due to its electrogenic mode of action (3
Na+: 1 Ca2+) NCX mediates membrane depolarization during
Ca2+ extrusion. Hence, NCXmay contribute to the development
of EADs and facilitate the translation of spontaneous SR
Ca2+ releases into DADs, which both may trigger arrhythmia
(Sipido et al., 2006; Pott et al., 2012; Bourgonje et al., 2013).
Consequently, pharmacological NCX inhibition should have
antiarrhythmic effects but may on the other hand increase the
cellular Ca2+ content, which could increase inotropy but also
adversely promote arrhythmia. Encouragingly, initial work has
demonstrated evidence for the antiarrhythmic efficacy of NCX
inhibition mediated by SEA0400. However, the present study
demonstrates, that the effects of SEA0400 on Ca2+ transient
amplitude and proarrhythmia in murine cardiomyocytes are
dependent on the NCX expression level.
The Effects of SEA0400 on the Ca2+
Transient Amplitude Depend on the NCX
Function
SEA0400 reduced the NCX forward mode function to a similar
extent in all mouse lines thus confirming inhibitory efficacy.
At the same time, SEA0400 mediated a significant increase of
the Ca2+ transient suggesting a positive inotropic effect in both
wild-types (WTOE; WThetKO) and hetKO but interestingly not
in OE.
Previous studies found a positive inotropic effect in response
to SEA0400 in murine, rat and pig models (Tanaka et al., 2005;
Farkas et al., 2008; Ozdemir et al., 2008). Other studies reported
rather neutral effects on contractility in rabbit, guinea pig and
dog models (Nagy et al., 2004; Tanaka et al., 2007; Bourgonje
et al., 2013). These diverse effects may be mostly attributable
to differences in Ca2+ handling and basic electrophysiological
properties between the various species. Analogous to cardiac
glycosides, NCX inhibition can result in a net gain of intracellular
Ca2+, which augments the Ca2+ transient amplitude and
consequently inotropy. SEA0400 seems tomediate such a positive
inotropic effect in smaller rodents (mouse and rat) but not
in higher mammals, with the exception for pigs. In smaller
rodents, the intracellular Na+ level is elevated compared to
higher mammals which results in a reversal potential for NCX
(ENa/Ca) close to the diastolic membrane potential (Em) reducing
the driving force for the NCX forward mode (Em-ENa/Ca)
(Bers, 2002). Moreover, Ca2+ removal from the cytosol in these
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FIGURE 3 | Quantification of spontaneous Ca2+ releases (sCR) as a measure for proarrhythmia. (A) Representative tracings illustrate the occurrence of numerous
sCR (arrows below respective tracings) between field-stimulated Ca2+ transients (stim, arrows above respective tracings) in OE but not in hetKO in absence of
SEA0400. (B) Quantification of sCR/cell under basal conditions and during exposure with 1 µM SEA0400. (C) Number of sCR-positive cardiomyocytes under basal
conditions and during exposure with 1 µM SEA0400. SEA0400 significantly reduced the occurrence of sCR/cell in OE. Conversely, in hetKO SEA0400 increased the
occurrence of sCR. Hence, the effect of SEA0400 on the occurrence of proarrhythmic spontaneous Ca2+ transients again depends on the NCX expression level.
*p < 0.05 vs. basal; +p < 0.05 vs. corresponding WT basal; two-way repeated measures ANOVA test; z-test.
species largely depends on sarco(endo-)plasmic reticulum Ca2+-
ATPase (SERCA) which mediates the re-uptake of Ca2+ ions
into the sarcoplasmic reticulum while NCX mediates Ca2+
extrusion to the extracellular compartment. In higher mammals,
the competition between SERCA and NCX shifts in favor of
NCX, although SERCA still removes the major proportion of
cytosolic Ca2+ (Puglisi et al., 1996). To assure a balanced Ca2+
homeostasis, the exact amount of Ca2+ entering the cell mainly
via L-type Ca2+ channels has to be extruded to the extracellular
compartment via NCX. Thus, SEA0400-mediated reduction of a
comparatively lowNCX-mediated Ca2+ removal rate as observed
in smaller rodents may more likely result in intracellular Ca2+
accumulation than in higher mammals which might explain
the observed different inotropic responses in different studies.
However, Ozdemir et al. found a positive inotropic response of
SEA0400 in pigs as an example for higher mammals (Ozdemir
et al., 2008). But they also found a lower NCX current in pig
compared to mice, which might explain the positive inotropy via
Ca2+ accumulation.
In contrast to both wild-types and hetKO, cardiomyocytes
from OE mice did not exhibit a significant increase in the
Ca2+ transient amplitude in response to SEA0400. In OE 1 µM
SEA0400 reduced the NCX-mediated Ca2+ removal rate on
average to a level ranging between the basal hetKO rate and the
rate of both wild-types (Figures 1B,D). A NCX-mediated Ca2+
removal rate as low as in hetKO mice under basal conditions
was not associated with a measurable increase of the amplitude
of Ca2+ transients as reported previously (Bögeholz et al., 2015).
Hence, the remaining NCX function in OE in presence of
SEA0400 seems to be still high enough to cope with Ca2+
removal and thus to avoid net gain of Ca2+ and consequently
an increase in Ca2+ transient amplitude. In this regard, the
inhibitory effect of SEA0400 on L-type Ca2+ current has also
to be taken into account (Birinyi et al., 2008). It has been
shown that SEA0400 inhibits the L-type Ca2+ current either
directly via pleiotropic effects, or indirectly by slowing the NCX-
mediated Ca2+ removal leading to an increase of subsarcolemmal
Ca2+ concentration which in turn promotes Ca2+ dependent
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FIGURE 4 | Quantification of Ca2+ hypercontractions as a measure for
proarrhythmia. In a fraction of cardiomyocytes application of 1µM SEA0400
caused a sudden increase of the diastolic Ca2+ level with highly frequent
contractions and subsequent cell death (“Ca2+ hypercontraction”) (B) as
illustrated by the representative tracing in (A). The proportion of cells with
Ca2+ hypercontractions was significantly increased only in the hetKO group.
*p < 0.05 vs. basal; +p < 0.05 vs. WT; Fisher’s exact test with R.
inactivation of L-type Ca2+ current (Pott et al., 2005; Bögeholz
et al., 2015).
Interestingly, Ozdemir et al. similarly found absence of a
positive inotropic effect in MLP-/- mice, a murine model of
heart failure (Ozdemir et al., 2008). Due to the heart failing
phenotype NCX upregulation is likely, which may prevent from
Ca2+ accumulation and positive inotropy. Taken together within
the same species the effect of the same concentration of SEA0400
on calcitropy and thus inotropy seems to depend on the NCX
expression level and corresponding function.
Effects of SEA0400 on Cellular
Proarrhythmia Depend on the NCX
Expression Level
In previous studies, SEA0400 exhibited antiarrhythmic efficacy
on cellular level by suppressing afterdepolarizations (Nagy
et al., 2004; Zhao et al., 2012), on whole heart level in vitro
(Milberg et al., 2008, 2012) and even in vivo in a canine model
(Nagasawa et al., 2005; Bourgonje et al., 2013). On the other
hand, proarrhythmic effects mediated by SEA0400 have been
reported as well (Ozdemir et al., 2008). The respective NCX
functionmight be considerably heterogeneous in the investigated
animal models, i.e., increased in the case of heart failure, or
effectively decreased in the setting of cardiac glycoside-induced
proarrhythmia. We here demonstrate that the effects of SEA0400
on cellular proarrhythmia again depend on the underlying
baseline NCX function within the same species. Considering
NCX inhibition as a promising therapeutic strategy, this might
be of translational relevance, since major cardiac diseases like
heart failure or atrial fibrillation are accompanied by NCX
upregulation, whereas other specific cardiac disease entities, like
the postinfarction (Zhang et al., 1996; Quinn et al., 2003) and
diabetic cardiomyopathy (Schaffer et al., 1997; Hattori et al.,
2000) exhibit a reduced NCX function, at least in animal models.
There also might be further specific disease entities with altered
NCX function that are yet to be further evaluated (Primessnig
et al., 2016).
SEA0400 Reduced Cellular Proarrhythmia
in OE
In OE, application of SEA0400 reduced the occurrence of
spontaneous Ca2+ transients. In a former study the increased
NCX expression and function in OE has been identified as
an independent proarrhythmic factor (Pott et al., 2012). Thus,
the observed reduction of arrhythmogenic spontaneous Ca2+
transients in OE can be attributed to the SEA0400-mediated
inhibition of NCX function.
The underlying molecular mechanism of SEA0400-mediated
decrease in the occurrence of spontaneous Ca2+ transients
in OE may consist of reduced NCX forward mode with
subsequently reduced depolarizing inward current thus avoiding
membrane depolarization and the occurrence of EADs and
DADs as proarrhythmic triggers. However, in this regard again
the inhibitory potency of SEA0400 on L-type Ca2+ current has
to be taken into account (Birinyi et al., 2008; Bourgonje et al.,
2013), which might contribute to the observed reduction of
proarrhythmic spontaneous Ca2+ transients in OE in presence
of SEA0400. Supplementary to these molecular mechanisms
of arrhythmia, we have previously demonstrated a significant
antiarrhythmic effect of SEA0400 on whole-heart arrhythmia
(ventricular tachycardia) in a rabbit model of heart failure
(Milberg et al., 2012). SEA0400 reduced the occurrence of
EADs due to a reduced monophasic action potential duration,
dispersion and QT interval. Thus, the antiarrhythmic effects of
SEA0400 may be diverse and apply to diverse functional levels.
Proarrhythmic Effects of SEA0400 in
Wild-Type and hetKO
In contrast to OE, SEA0400 led to an increased occurrence
of spontaneous Ca2+ transients in WTOE, WThetKO, and
hetKO. Furthermore, Ca2+ homeostasis seemed to be drastically
impaired in hetKO treated with SEA0400 as reflected in the
increase percentage of cardiomyocytes with hypercontraction
and subsequent cell death as a consequence of cytosolic Ca2+
overload. Based on these observations, it seems likely that
a critical level of NCX function must remain after SEA0400
treatment to avoid detrimental intracellular Ca2+ accumulation
and overload. While the reduced basal NCX function in hetKO
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led to a phenotype with reduced likelihood of arrhythmia and
a balanced Ca2+ homeostasis as reported previously (Bögeholz
et al., 2015), lowering NCX function below this level with
SEA0400 was clearly detrimental in hetKO,WThetKO, andWTOE.
In this regard, one has to distinguish between acute reduction
of NCX function via SEA0400 and chronically reduced NCX
function via transgenic manipulation. The latter offers the
opportunity for long-term adaption beginning from the early
stages of development to compensate for the reduced Ca2+
removal rate mediated via NCX. The most important adaptive
mechanism in models with reduced (Bögeholz et al., 2015) or
absent NCX function (Pott et al., 2007a,b,c) to keep a balanced
Ca2+ homeostasis consists of a reduced Ca2+ entry via the L-
type Ca2+ channel as mediated by an enhanced Ca2+-dependent
inactivation of the L-type Ca2+ current. Thus, if less Ca2+
enters the cell, the reduced NCX function is still sufficient to
keep a balanced Ca2+ homeostasis in a chronically adapted
system. In contrast, the lack of time for adaptation to acute NCX
inhibition by SEA0400 may contribute to the impaired Ca2+
homeostasis in WT and most prominently in hetKO. However,
in OE acute application of SEA0400 was not detrimental
but reduced the cellular proarrhythmia through acute NCX
inhibition. Thus, depending on the baseline NCX expression
level, acute SEA0400 application can cause destabilization of
intracellular Ca2+ homeostasis leading to arrhythmia and cell
death or mediate antiarrhythmic effects.
CONCLUSION AND TRANSLATIONAL
PERSPECTIVE
In conclusion, our results suggest that within the same species
beneficial or detrimental effects mediated by SEA0400 depend
upon the basal NCX expression and thus function level. A
reduced NCX function level as low as that in hetKO has been
shown to be antiarrhythmic (Bögeholz et al., 2015). Reducing
an already increased proarrhythmic NCX function level, such as
that in OE (Pott et al., 2012), by SEA0400 to the baseline hetKO
level reduces proarrhythmia without increasing the amplitude
of Ca2+ transients. Reducing the NCX function level below this
value increases the amplitude of Ca2+ transients due to SR Ca2+
loading but at the same time mediates cellular proarrhythmia
as demonstrated in WThetKO, WTOE and most prominently
in hetKO where the remaining NCX function is the lowest.
Consistent with this observation, a previous study demonstrated
an enhanced susceptibility toward arrhythmia in a ventricular
specific homozygous NCX knockout mouse model with absence
of NCX expression in 80–90% of ventricular cardiomyocytes
(Jordan et al., 2010). Taken together, these findings suggest that
NCX inhibition may be beneficial, however there seems to be a
critical level of the remaining NCX function that is needed for
balanced Ca2+ homeostasis. In case of falling below a certain
critical threshold, adverse effects occur due to Ca2+ accumulation
promoting proarrhythmia (Table 1). Translated into the clinical
context, NCX inhibition may be antiarrhythmic in absence of
a negative inotropic effect in conditions of increased NCX
expression as present in heart failure or atrial fibrillation. Albeit,
TABLE 1 | Summary of the effects of SEA0400 on Ca2+ handling in dependence
on the NCX expression level.
NCX expression OE WTOE WThetKO hetKO
320% 100% 100% 47%
SEA0400 effect
Remaining NCX function ↓ ↓↓ ↓↓ ↓↓↓
Ca2+ transient amplitude ↔ ↑ ↑ ↑
Proarrhythmic effect ↓ ↑ ↑ ↑↑
Antiarrhythmic effect ↑ ↓ ↓ ↓↓
SEA0400 reduced the NCX forward mode function in all mouse lines but to different
remaining NCX function levels. This results in a positive inotropic effect in the presence
of unaltered or reduced NCX expression in hetKO and both WTs, but not in face of
increased NCX expression in OE. SEA0400 reduced spontaneous Ca2+ transients in OE
but oppositely mediated a proarrhythmic effect under conditions of unaltered or reduced
NCX expression. These comparative results indicate that the occurrence of detrimental
or beneficial effects of SEA0400 depend on the remaining NCX function present during
NCX inhibition.
in conditions of preexisting reduced NCX function, as observed
in animal models of postinfarction or diabetic cardiomyopathy,
additional NCX inhibition may potentially exert proarrhythmic
effects accompanied by increased inotropy due to a reduction
of the remaining NCX function below a critical level that is
needed for balancing the cellular Ca2+ dynamics. Thus, at-risk
groups should be identified in future large-scaled clinical trials
investigating specific NCX inhibitors.
Limitations
In this study, the Ca2+ transient amplitude served as a proxy
measure for inotropy on the cellular level. Though an acute
increase of the Ca2+ transient amplitude is usually accompanied
by a simultaneous increase in contractility, we did not measure
changes in contractility directly. Likewise, although spontaneous
Ca2+ releases represent a well-known proarrhythmic substrate,
it has to be acknowledged, that clinically relevant whole-heart
arrhythmia is a more complex result from a magnitude of
involved factors. Thus, future studies should investigate the in
vivo-relevance of our findings derived from the cellular level.
Moreover, our findings may not be uncritically transferable
into the human (patho-)physiology, since there are substantial
differences in cardiac Ca2+ cycling und electrophysiology
compared to a murine model. It remains also to be tested
whether more specific NCX inhibitors show comparable effects
to SEA0400. However, despite these limitations our data suggest
that care should be taken when testing NCX inhibitors in
clinical studies where we usually do not know the respective
NCX expression and function level of individuals, which might
determine beneficial or detrimental effects of the treatment
approach with an NCX inhibitor.
AUTHOR CONTRIBUTIONS
NB, JS, SK, CP, and FM designed the study. NB, JS, SK, BB, and
PP acquired the data. NB, JS, SK, BB, and DD performed the
Frontiers in Pharmacology | www.frontiersin.org 8 September 2017 | Volume 8 | Article 649
Bögeholz et al. SEA0400 Effects Depend on NCX Expression
statistical analysis. All authors contributed substantially to the
interpretation of the data. NB, JS, and SK wrote the manuscript.
BB, PP, DD, GF, JG, UK, LE, CP, and FM critically revised
the manuscript. All authors approved the final version of the
manuscript.
FUNDING
This work was supported by the Deutsche Stiftung für
Herzforschung (F/44/12) to CP, LE, and FM. LE and GF are
supported by the Peter-Osypka-Foundation.
REFERENCES
Adachi-Akahane, S., Lu, L., Li, Z., Frank, J. S., Philipson, K. D., and Morad, M.
(1997). Calcium signaling in transgenic mice overexpressing cardiac Na(+)-
Ca2+ exchanger. J. Gen. Physiol. 109, 717–729. doi: 10.1085/jgp.109.6.717
Bassani, J. W., Bassani, R. A., and Bers, D. M. (1994). Relaxation in rabbit and rat
cardiac cells: species-dependent differences in cellular mechanisms. J. Physiol.
476, 279–293. doi: 10.1113/jphysiol.1994.sp020130
Bers, D. M. (2002). Cardiac Na/Ca exchange function in rabbit, mouse
and man: what’s the difference? J. Mol. Cell. Cardiol. 34, 369–373.
doi: 10.1006/jmcc.2002.1530
Birinyi, P., Acsai, K., Banyasz, T., Toth, A., Horvath, B., Virag, L., et al. (2005).
Effects of SEA0400 and KB-R7943 on Na+/Ca2+ exchange current and L-type
Ca2+ current in canine ventricular cardiomyocytes. Naunyn Schmiedebergs.
Arch. Pharmacol. 372, 63–70. doi: 10.1007/s00210-005-1079-x
Birinyi, P., Toth, A., Jona, I., Acsai, K., Almassy, J., Nagy, N., et al. (2008). The
Na+/Ca2+ exchange blocker SEA0400 fails to enhance cytosolic Ca2+ transient
and contractility in canine ventricular cardiomyocytes. Cardiovasc. Res. 78,
476–484. doi: 10.1093/cvr/cvn031
Bögeholz, N., Pauls, P., Bauer, B. K., Schulte, J. S., Dechering, D. G., Frommeyer, G.,
et al. (2015). Suppression of early and late afterdepolarizations by heterozygous
knockout of the Na+/Ca2+ exchanger in a murine model. Circ. Arrhythm.
Electrophysiol. 8, 1210–1218. doi: 10.1161/CIRCEP.115.002927
Bögeholz, N., Pauls, P., Kaese, S., Schulte, J. S., Lemoine, M. D., Dechering,
D. G., et al. (2016). Triggered activity in atrial myocytes is influenced by
Na+/Ca2+ exchanger activity in genetically altered mice. J. Mol. Cell. Cardiol.
101, 106–115. doi: 10.1016/j.yjmcc.2016.11.004
Bourgonje, V. J., Vos, M. A., Ozdemir, S., Doisne, N., Acsai, K., Varro, A.,
et al. (2013). Combined Na(+)/Ca(2+) exchanger and L-type calcium
channel block as a potential strategy to suppress arrhythmias and
maintain ventricular function. Circ. Arrhythm. Electrophysiol. 6, 371–379.
doi: 10.1161/CIRCEP.113.000322
Farkas, A. S., Acsai, K., Nagy, N., Toth, A., Fulop, F., Seprenyi, G., et al. (2008).
Na(+)/Ca(2+) exchanger inhibition exerts a positive inotropic effect in the rat
heart, but fails to influence the contractility of the rabbit heart. Br. J. Pharmacol.
154, 93–104. doi: 10.1038/bjp.2008.83
Hattori, Y., Matsuda, N., Kimura, J., Ishitani, T., Tamada, A., Gando, S.,
et al. (2000). Diminished function and expression of the cardiac Na+-Ca2+
exchanger in diabetic rats: implication in Ca2+ overload. J. Physiol. 527(Pt 1),
85–94. doi: 10.1111/j.1469-7793.2000.00085.x
Henderson, S. A., Goldhaber, J. I., So, J. M., Han, T., Motter, C., Ngo,
A., et al. (2004). Functional adult myocardium in the absence of Na+-
Ca2+ exchange: cardiac-specific knockout of NCX1. Circ. Res. 95, 604–611.
doi: 10.1161/01.RES.0000142316.08250.68
Iwamoto, T., Watano, T., and Shigekawa, M. (1996). A novel isothiourea derivative
selectively inhibits the reverse mode of Na+/Ca2+ exchange in cells expressing
NCX1. J. Biol. Chem. 271, 22391–22397. doi: 10.1074/jbc.271.37.22391
Jordan, M. C., Henderson, S. A., Han, T., Fishbein, M. C., Philipson,
K. D., and Roos, K. P. (2010). Myocardial function with reduced
expression of the sodium-calcium exchanger. J. Card. Fail. 16, 786–796.
doi: 10.1016/j.cardfail.2010.03.012
Li, Z., Nicoll, D. A., Collins, A., Hilgemann, D. W., Filoteo, A. G., Penniston, J.
T., et al. (1991). Identification of a peptide inhibitor of the cardiac sarcolemmal
Na(+)-Ca2+ exchanger. J. Biol. Chem. 266, 1014–1020.
Menick, D. R., Renaud, L., Buchholz, A., Muller, J. G., Zhou, H., Kappler, C. S., et al.
(2007). Regulation of Ncx1 gene expression in the normal and hypertrophic
heart. Ann. N. Y. Acad. Sci. 1099, 195–203. doi: 10.1196/annals.1387.058
Milberg, P., Pott, C., Fink, M., Frommeyer, G., Matsuda, T., Baba, A., et al. (2008).
Inhibition of the Na+/Ca2+ exchanger suppresses torsades de pointes in an
intact heart model of long QT syndrome-2 and long QT syndrome-3. Heart
Rhythm 5, 1444–1452. doi: 10.1016/j.hrthm.2008.06.017
Milberg, P., Pott, C., Frommeyer, G., Fink, M., Ruhe, M., Matsuda, T., et al.
(2012). Acute inhibition of the Na(+)/Ca(2+) exchanger reduces proarrhythmia
in an experimental model of chronic heart failure. Heart Rhythm 9, 570–578.
doi: 10.1016/j.hrthm.2011.11.004
Nagasawa, Y., Zhu, B. M., Chen, J., Kamiya, K., Miyamoto, S., and Hashimoto,
K. (2005). Effects of SEA0400, a Na+/Ca2+ exchange inhibitor, on ventricular
arrhythmias in the in vivo dogs. Eur. J. Pharmacol. 506, 249–255.
doi: 10.1016/j.ejphar.2004.11.011
Nagy, N., Kormos, A., Kohajda, Z., Szebeni, A., Szepesi, J., Pollesello, P.,
et al. (2014). Selective Na(+) /Ca(2+) exchanger inhibition prevents Ca(2+)
overload-induced triggered arrhythmias. Br. J. Pharmacol. 171, 5665–5681.
doi: 10.1111/bph.12867
Nagy, Z. A., Virag, L., Toth, A., Biliczki, P., Acsai, K., Banyasz, T., et al. (2004).
Selective inhibition of sodium-calcium exchanger by SEA-0400 decreases early
and delayed after depolarization in canine heart. Br. J. Pharmacol. 143, 827–831.
doi: 10.1038/sj.bjp.0706026
Namekata, I., Tsuneoka, Y., Takahara, A., Shimada, H., Sugimoto, T., Takeda, K.,
et al. (2009). Involvement of the Na(+)/Ca(2+) exchanger in the automaticity of
guinea-pig pulmonary vein myocardium as revealed by SEA0400. J. Pharmacol.
Sci. 110, 111–116. doi: 10.1254/jphs.08159SC
O’Neill, S. C., Donoso, P., and Eisner, D. A. (1990). The role of [Ca2+]i
and [Ca2+] sensitization in the caffeine contracture of rat myocytes:
measurement of [Ca2+]i and [caffeine]i. J. Physiol. 425, 55–70.
doi: 10.1113/jphysiol.1990.sp018092
Ozdemir, S., Bito, V., Holemans, P., Vinet, L., Mercadier, J. J., Varro, A., et al.
(2008). Pharmacological inhibition of na/ca exchange results in increased
cellular Ca2+ load attributable to the predominance of forward mode block.
Circ. Res. 102, 1398–1405. doi: 10.1161/CIRCRESAHA.108.173922
Pott, C., Henderson, S. A., Goldhaber, J. I., and Philipson, K. D. (2007a). Na+/Ca2+
exchanger knockout mice: plasticity of cardiac excitation-contraction coupling.
Ann. N. Y. Acad. Sci. 1099, 270–275. doi: 10.1196/annals.1387.015
Pott, C., Muszynski, A., Ruhe, M., Bogeholz, N., Schulte, J. S., Milberg, P.,
et al. (2012). Proarrhythmia in a non-failing murine model of cardiac-specific
Na+/Ca2+ exchanger overexpression: whole heart and cellular mechanisms.
Basic Res. Cardiol. 107, 247. doi: 10.1007/s00395-012-0247-7
Pott, C., Philipson, K. D., and Goldhaber, J. I. (2005). Excitation-contraction
coupling in Na+-Ca2+ exchanger knockout mice: reduced transsarcolemmal
Ca2+ flux. Circ. Res. 97, 1288–1295. doi: 10.1161/01.RES.0000196563.84231.21
Pott, C., Ren, X., Tran, D. X., Yang, M. J., Henderson, S., Jordan, M. C.,
et al. (2007b). Mechanism of shortened action potential duration in Na+-
Ca2+ exchanger knockout mice. Am. J. Physiol. Cell Physiol. 292, C968–C973.
doi: 10.1152/ajpcell.00177.2006
Pott, C., Yip, M., Goldhaber, J. I., and Philipson, K. D. (2007c). Regulation of
cardiac L-type Ca2+ current inNa+-Ca2+ exchanger knockoutmice: functional
coupling of the Ca2+ channel and the Na+-Ca2+ exchanger. Biophys. J. 92,
1431–1437. doi: 10.1529/biophysj.106.091538
Primessnig, U., Schonleitner, P., Holl, A., Pfeiffer, S., Bracic, T., Rau, T., et al.
(2016). Novel pathomechanisms of cardiomyocyte dysfunction in a model of
heart failure with preserved ejection fraction. Eur. J. Heart Fail. 18, 987–997.
doi: 10.1002/ejhf.524
Priori, S. G., Blomstrom-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M.,
Camm, J., et al. (2015). 2015 ESC guidelines for the management of patients
with ventricular arrhythmias and the prevention of sudden cardiac death: the
task force for the management of patients with ventricular arrhythmias and
the prevention of sudden cardiac death of the European Society of Cardiology
(ESC)endorsed by: association for European Paediatric and Congenital
Cardiology (AEPC). Eur. Heart J. 36, 2793–2867. doi: 10.1093/eurheartj/ehv316
Frontiers in Pharmacology | www.frontiersin.org 9 September 2017 | Volume 8 | Article 649
Bögeholz et al. SEA0400 Effects Depend on NCX Expression
Puglisi, J. L., Bassani, R. A., Bassani, J. W., Amin, J. N., and Bers, D. M. (1996).
Temperature and relative contributions of Ca transport systems in cardiac
myocyte relaxation. Am. J. Physiol. 270, H1772–1778.
Quinn, F. R., Currie, S., Duncan, A. M., Miller, S., Sayeed, R., Cobbe, S. M.,
et al. (2003). Myocardial infarction causes increased expression but decreased
activity of the myocardial Na+-Ca2+ exchanger in the rabbit. J. Physiol. 553,
229–242. doi: 10.1113/jphysiol.2003.050716
Reuter, H., Henderson, S. A., Han, T., Matsuda, T., Baba, A., Ross, R.
S., et al. (2002). Knockout mice for pharmacological screening: testing
the specificity of Na+-Ca2+ exchange inhibitors. Circ. Res. 91, 90–92.
doi: 10.1161/01.RES.0000027529.37429.38
Schaffer, S. W., Ballard-Croft, C., Boerth, S., and Allo, S. N. (1997). Mechanisms
underlying depressed Na+/Ca2+ exchanger activity in the diabetic heart.
Cardiovasc. Res. 34, 129–136. doi: 10.1016/S0008-6363(97)00020-5
Schulte, J. S., Seidl, M. D., Nunes, F., Freese, C., Schneider, M., Schmitz, W., et al.
(2012). CREB critically regulates action potential shape and duration in the
adult mouse ventricle. Am. J. Physiol. Heart Circ. Physiol. 302, H1998–H2007.
doi: 10.1152/ajpheart.00057.2011
Sipido, K. R., Varro, A., and Eisner, D. (2006). Sodium calcium exchange as
a target for antiarrhythmic therapy. Handb. Exp. Pharmacol. 171, 159–199.
doi: 10.1007/3-540-29715-4_6
Tanaka, H., Namekata, I., Takeda, K., Kazama, A., Shimizu, Y., Moriwaki,
R., et al. (2005). Unique excitation-contraction characteristics of mouse
myocardium as revealed by SEA0400, a specific inhibitor of Na+-
Ca2+ exchanger. Naunyn Schmiedebergs. Arch. Pharmacol. 371, 526–534.
doi: 10.1007/s00210-005-1051-9
Tanaka, H., Shimada, H., Namekata, I., Kawanishi, T., Iida-Tanaka, N.,
and Shigenobu, K. (2007). Involvement of the Na+/Ca2+ exchanger
in ouabain-induced inotropy and arrhythmogenesis in guinea-pig
myocardium as revealed by SEA0400. J. Pharmacol. Sci. 103, 241–246.
doi: 10.1254/jphs.FP0060911
Voigt, N., Li, N., Wang, Q., Wang, W., Trafford, A. W., Abu-Taha, I.,
et al. (2012). Enhanced sarcoplasmic reticulum Ca2+ leak and increased
Na+-Ca2+ exchanger function underlie delayed afterdepolarizations
in patients with chronic atrial fibrillation. Circulation 125, 2059–2070.
doi: 10.1161/CIRCULATIONAHA.111.067306
Zhang, X. Q., Tillotson, D. L., Moore, R. L., Zelis, R., and Cheung, J. Y.
(1996). Na+/Ca2+ exchange currents and SR Ca2+ contents in postinfarction
myocytes. Am. J. Physiol. 271, C1800–C1807.
Zhao, S. M., Wang, Y. L., Guo, C. Y., Chen, J. L., andWu, Y. Q. (2014). Progressive
decay of Ca2+ homeostasis in the development of diabetic cardiomyopathy.
Cardiovasc. Diabetol. 13:75. doi: 10.1186/1475-2840-13-75
Zhao, Z., Wen, H., Fefelova, N., Allen, C., Baba, A., Matsuda, T., et al.
(2012). Revisiting the ionic mechanisms of early afterdepolarizations in
cardiomyocytes: predominant by Cawaves or Ca currents?Am. J. Physiol. Heart
Circ. Physiol. 302, H1636–H1644. doi: 10.1152/ajpheart.00742.2011
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2017 Bögeholz, Schulte, Kaese, Bauer, Pauls, Dechering, Frommeyer,
Goldhaber, Kirchhefer, Eckardt, Pott and Müller. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Pharmacology | www.frontiersin.org 10 September 2017 | Volume 8 | Article 649
